Protective effects of Kurozu and Kurozu Moromimatsu on dextran sulfate sodium-induced experimental colitis

Digestive Diseases and Sciences

Volumn 56, Issue 5, 2011, Pages 1387-1392

  Shizuma, Toru ^a   Ishiwata, Kazuo ^a   Nagano, Masanobu ^b   Mori, Hidezo ^a   Fukuyama, Naoto ^a  

^a TOKAI UNIVERSITY   (Japan)

^b Sakamoto Kurozu Inc   (Japan)

Author keywords

Colitis; Dextran sulfate sodium; Kurozu; Kurozu Moromimatsu; Nitrotyrosine

Indexed keywords

3 NITROTYROSINE; ACETIC ACID; DEXTRAN SULFATE; VINEGAR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; COLITIS; CONTROLLED STUDY; EXPERIMENTAL COLITIS; FEMALE; HEMATOCHEZIA; KUROZO MOROMIMATSU; KUROZU; MORBIDITY; MOUSE; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; TRADITIONAL MEDICINE; WEIGHT REDUCTION;

ACETIC ACID; ANIMALS; COLITIS; DEXTRAN SULFATE; FERMENTATION; MICE; ORYZA SATIVA; WEIGHT LOSS;

EID: 79955612852     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-010-1432-x     Document Type: Article

References (32)

1. Murooka Y, Yamashita M. Traditional healthful fermented products of Japan. J Ind Microbiol Biotechnol. 2008;35:791-798.
2. Nakayama S, Saikawa M, Yamaura T, et al. Antihypertensive effect of Kurosu, extract: A traditional vinegar produced from unpolished rice, in SHR rats. Clin Pharm Ther. 2001;11:567-573. (in Japanese).
3. Shimoji Y, Sugie S, Kohno H, et al. Extract of vinegar "Kurosu" from unpolished rice inhibits the development of colonic aberrant crypt foci induced by azoxymethane. J Exp Clin Cancer Res. 2003;22:591-597.
4. Shimoji Y, Kohno H, Nanda K, et al. Extract of Kurosu, a vinegar from unpolished rice, inhibits azoxymethane-induced colon carcinogenesis in male F344 rats. Nutr Cancer. 2004;49:170-173. (Pubitemid 39487876)
5. Nanda K, Miyoshi N, Nakamura Y, et al. Extract of vinegar "Kurosu" from unpolished rice inhibits the proliferation of human cancer cells. J Exp Clin Cancer Res. 2004;23:69-75.
6. Fukuyama N, Jujo S, Ito I, et al. Kurozu moromimatsu inhibits tumor growth of LoVo cells in a mouse model in vivo. Nutrition. 2007;23:81-86. (Pubitemid 44959769)
7. Nishidai S, Nakamura Y, Torikai K, et al. Kurosu, a traditional vinegar produced from unpolished rice, suppresses lipid peroxidation in vitro and in mouse skin. Biosci Biotechnol Biochem. 2000;64:1909-1914.
8. Babbs CF. Oxygen radicals in ulcerative colitis. Free Radic Biol Med. 1992;13:169-181.
9. Hong SK, Chaturvedi R, Piazuelo MB, et al. Increased expression and cellular localization of spermine oxidase in ulcerative colitis and relationship to disease activity. Inflamm Bowel Dis. 2010;16:1557-1566.
10. Schindhelm RK, van der Zwan LP, Teerlink T, et al. Myeloperoxidase: A useful biomarker for cardiovascular disease risk stratification? Clin Chem. 2009;55:1462-1470.
11. Radi R. Peroxynitrite and reactive nitrogen species: the contribution of ABB in two decades of research. Arch Biochem Biophys. 2009;484:111-113.
12. Beckman JS, Beckmen TW, Chen J, et al. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA. 1990;87:1620-1624.
13. Cross RK, Wilson KT. Nitric oxide in inflammatory bowel disease. Inflamm Bowel Dis. 2003;9:179-189. (Pubitemid 36592449)
14. Akuta T, Zaki MH, Yoshitake J, et al. Nitrative stress through formation of 8-nitroguanosine: Insights into microbial pathogenesis. Nitric Oxide. 2006;14:101-108. (Pubitemid 43165875)
15. Ameho CK, Adjei AA, Harrison EK, et al. Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumor necrosis factor alpha production in trinitrobenzene sulphonic acid induced colitis. Gut. 1997;41:487-493. (Pubitemid 27448780)
16. Grudziński IP, Frankiewicz-Jóźko A. Nitric oxide synthase inhibitors reduced lipid peroxidation in N-nitrosodiethylamine-treated rats. Rocz Panstw Zaki Hig. 2001;52:89-95.
17. Wu G. Amino acids: Metabolism, functions, and nutrition. Amino Acids. 2009;37:1-17.
18. Kim CJ, Kovacs-Nolan JA, Yang C, et al. L-cysteine supplementation attenuates local inflammation and restores gut homeostasis in a porcine model of colitis. Biochem Biophys Acta. 2009;1790:1161-1169.
19. Faure M, Mettraux C, Moennoz D, et al. Specific amino acids increase mucin synthesis and microbiota in dextran sulfate sodium-treated rats. J Nutr. 2006;136:1558-1564. (Pubitemid 43765362)
20. Kim CJ, Kovacs-Nolan JA, Yang C, et al. l-Tryptophan exhibits therapeutic function in a porcine model of dextran sodium sulfate (DSS)-induced colitis. J Nutr Biochem. 2010;21:468-475.
21. Liao J, Seril DN, Yang AL, et al. Inhibition of chronic ulcerative colitis associated adenocarcinoma development in mice by inositol compounds. Carcinogenesis. 2007;28:446-454. (Pubitemid 46321862)
22. Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: Antibiotics, probiotics, and prebiotics. Gastroenterology. 2004;126:1620-1633. (Pubitemid 38649878)
23. Williams NT. Probiotics. Am J Health Syst Pharm. 2010;67:449-458.
24. Kanauchi O, Mitsuyama K, Andoh A. The therapeutic impact of manipulating microbiota in inflammatory bowel disease. Curr Pharm Des. 2009;15:2074-2086.
25. Fujimori S, Gudis K, Mitsui K, et al. A randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis. Nutrition. 2009;25:520-525.
26. Lee IH, Hung YH, Chou CC. Solid-state fermentation with fungi to enhance the antioxidative activity, total phenolic and anthocyanin contents of black bean. Int J Food Microbiol. 2008;121:150-156.
27. Fukuda Y, Tao Y, Tomita T, et al. A traditional Japanese medicine mitigates TNBS-induced colitis in rats. Scand J Gastroenterol. 2006;41:1183-1189. (Pubitemid 44451681)
28. Watanabe T, Nagawa H. Epidemiology of ulcerative colitis comparison between Japan and Western countries. Nippon Rinsho. 2005;63:750-756. (in Japanese).
29. van Lierop PP, Samsom JN, Escher JC, et al. Role of the innate immune system in the pathogenesis of inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2009;48:142-151.
30. Polińska B, Matowicka-Karna J, Kemona H. The cytokines in inflammatory bowel disease. Postepy Hig Med Dosw. 2009;63:389-394.
31. Ghosh N, Chaki R, Mandal V, et al. Mechanisms and efficacy of immunobiologic therapies for inflammatory bowel diseases. Int Rev Immunol. 2010;29:4-37.
32. Rogler G. Medical management of ulcerative colitis. Dig Dis. 2009;27:542-549.